必应词典为您提供multiple-myeloma的释义,un. 多发性骨髓瘤; 网络释义: 多发性骨髓癌;多发性骨瘤;则以多发性骨髓瘤;
Data Support Real-World Use of Ide-cel in R/R CNS Multiple Myeloma Jonah Feldman December 12th 2024 Real-world data show that CAR T-cell therapy may be considered for eligible patients with relapsed/refractory multiple myeloma harboring CNS involvement. ...
Peers Evaluate CAR T Referral and Bridging Process for Early Relapsed Multiple Myeloma By Targeted Oncology Staff December 27th 2024 During a Case-Based Roundtable® event, Hira Shaikh, MD, and participants discussed how they would treat a patient with lenalidomide-refractory multiple myeloma after ...
Indolent multiple myeloma:People with this type of myeloma have an elevated number of abnormal plasma cells in the bone marrow that may or may not produce monoclonal protein. They also have mild anemia or a few bone lesions, but they have no symptoms. The disease may remain stable for long ...
Transforming growth factor-β1: differential effects on multiple myeloma versus normal B cells Blood, 87 (1996), pp. 1928-1938 View PDFView articleView in ScopusGoogle Scholar 39 F Sallusto, M Cella, C Danieli, A Lanzavecchia Dendritic cells use macropinocytosis and the mannose receptor to conc...
The article presents s of studies about multiple myeloma, including an examination of plerixafor and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF) to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma and an assessment ...
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myelo... PURPOSE: To compare combination chemotherapy (CCT) versus melphalan plus prednisone (MP) as treatment for multiple myeloma. PATIENTS AND METHODS...
The multiple myeloma condition center is a comprehensive resource for clinical news and expert insights on multiple myeloma. Read more at OncLive.
Lerma, MD Multiple myeloma is defined as a malignant proliferation of a single clone of plasma cells resulting in monoclonal immunoglobulin production. It is often associated with extensive skeletal destruction, infections, anemia, hypercalcemia, and renal failure. Due to its multi-system consequences,...
Multiple myeloma represents about 1% of all cancers and 10–20% of all hematologic malignancies. The clonal proliferation of malignant plasma cells in the bone marrow may result both in local growth and in systemic effects due to the overproduction of a monoclonal protein (M-protein). Plasma cel...